American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer (vol 22, pg 2927, 2004)

被引：0

|

作者：

Loblaw

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 21期

关键词：

D O I：

10.1200/JCO.2004.08.943

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：4435 / 4435

页数：1

相关论文

共 15 条

[1] American society of clinical oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer
Loblaw, DA
Mendelson, DS
Talcott, JA
Virgo, KS
Somerfield, MR
Ben-Josef, E
Middleton, R
Porterfield, H
Sharp, SA
Smith, TJ
Taplin, ME
Vogelzang, NJ
Wade, JL
Bennett, CL
Scher, HI
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 2927 - 2941
[2] Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology Practice Guideline
Loblaw, D. Andrew
Virgo, Katherine S.
Nam, Robert
Somerfield, Mark R.
Ben-Josef, Edgar
Mendelson, David S.
Middleton, Richard
Sharp, Stewart A.
Smith, Thomas J.
Talcott, James
Taplin, Maryellen
Vogelzang, Nicholas J.
Wade, James L., III
Bennett, Charles L.
Scher, Howard I.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1596 - 1605
[3] Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American society of clinical oncology practice guideline" (vol 25, pg 1596, 2007)
Loblaw
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) : 4512 - 4512
[4] 2007 Update of ASCO Practice Guideline for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: Guideline Summary
Loblaw, D. Andrew
Virgo, Katherine S.
Nam, Robert
Somerfield, Mark R.
Ben-Josef, Edgar
Mendelson, David S.
Middleton, Richard
Sharp, Stewart A.
Smith, Thomas J.
Talcott, James
Taplin, Mary-Ellen
Vogelzang, Nicholas J.
Wade, James L.
Bennett, Charles L.
Scher, Howard I.
JOURNAL OF ONCOLOGY PRACTICE, 2007, 3 (03) : 175 - 177
[5] 2006 Update of ASCO Practice Guideline for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: Guideline Summary (Vol 2, pg 175, 2007)
Oratz, R.
JOURNAL OF ONCOLOGY PRACTICE, 2007, 3 (05) : 287 - 287
[6] American Society of Clinical Oncology recommendations on fertility preservation in cancer patients (vol 24, pg 4963, 2006)
不详
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) : 5790 - 5790
[7] Saudi Oncology Society clinical management guidelines for prostate cancer (vol 3, pg S10, 2011)
Abusamra, Ashraf J.
UROLOGY ANNALS, 2011, 3 (02) : 61 - 61
[8] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (vol 28, pg 2784, 2010)
Hammond, M. Elizabeth H.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3543 - 3543
[9] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (vol 134, pg 907, 2010)
Hammond
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (08) : 1101 - 1101
[10] Second-Line Hormonal Therapy for Men With Chemotherapy-Naive, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion (vol 13, pg 459, 2017)
Virgo, Katherine S.
Basch, Ethan
Loblaw, D. Andrew
Oliver, Thomas K.
Rumble, R. Bryan
Carducci, Michael A.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (36) : 4096 - 4096